NASDAQ

Research Alliance Corporation IV - Class A Ordinary Shares (RACD)

649 Thanks from members

Research Alliance Corporation IV (RACD) trades at a premium to its trust value, driven by sponsor RA Capital Management's strong healthcare exit track record, balanced by structural misalignments from low-cost founder shares and early-stage blank check risks.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →